overlay landing page

We have 384 Active VC firms in New Jersey on Angels Partners

main investor picture
Delaware Crossing Investor Group
Investing in Robotics • Life Science
 Philadelphia , Warrin..., United States
Investor Picture
Previous Investments
  • • Novira Therapeutics: $25000000 (Early stage VC)
  • • QR Pharma: $5700000 (Early stage VC)
  • • Medcura: $3020000 (Early stage VC)
  • • Life.io: $1500000 (Seed Round)
  • • Stabiliz Orthopaedics: $1280000 (Seed Round)
  • • Compliance Assurance: $1250000 (Later stage VC)
  • • NanoPack: $1100000 (Later stage VC)
  • • Hulafrog: $500000 (Seed Round)
  • • Snowvation: $500000 (Seed Round)

Delaware Crossing Investor Group

Philadelphia - Warrington, United States

Contact this investors  
Investing In

Robotics • Life Science

Description

Delaware Crossing Investor Group is a network of former and current executives and entrepreneurs who provide counsel and capital to early-stage and growing companies. The firm is a membership organization of investors who manage the investment process and serve as the board of directors of portfolio companies. It is based in Warrington, Pennsylvania and was founded in 2005.

main investor picture
Edison Partners
Investing in Software (Web Marketplace Saas..) &b...
 Princeton New Jersey, U.S.A.
  • main investor picture
    Christopher Clarke
    Partner
  • main investor picture
    Lenard Marcus
    Partner
  • main investor picture
    David Nevas
    Partner
  • main investor picture
    Daniel Herscovici
    Partner
  • main investor picture
    Del Giannotti
    Associate
  • main investor picture
    Gary Golding
    General Partner
  • main investor picture
    Gregg Michaelson
    Partner
  • main investor picture
    Jay Ganesan
    Analyst
  • main investor picture
    Joe Allegra
    General Partner
  • main investor picture
    Kelly Ford Buckley
    General Partner
  • main investor picture
    Michael Kopelman
    General Partner
  • main investor picture
    Robert Dickey
    Senior Associate
  • main investor picture
    Tom Vander Schaaff
    General Partner
  • main investor picture
    Chris Sugden
    Managing Partner
  • main investor picture
    Jonathan Reynolds
    Senior Associate
  • main investor picture
    Joseph Giquinto
    Vice President, Finance
  • main investor picture
    Ryan Ziegler
    General Partner
  • main investor picture
    Tom Schaaff
    Partner
  • main investor picture
    Christopher Clark
    Partner
  • main investor picture
    Joseph Allegra
    Partner
  • main investor picture
    Jay Naik
    Partner
Investor Picture
Previous Investments
  • • LookBookHQ Inc.: $13000000 (Later stage VC)
  • • tracx: $12500000 (Later stage VC)
  • • LawnStarter: $10500000 (Later stage VC)
  • • Zagster: $10000000 (Later stage VC)
  • • GAN Integrity Inc: $9000000 (Early stage VC)
  • • Solovis: $8000000 (Early stage VC)
  • • Signet Accel: $8000000 (Early stage VC)
  • • Loci.io: $350000 (Early stage VC)
  • • Emplify:
  • • SPHERE Technology Solutions: $31000000 (Series B)
  • • Get Spiffy: $30000000 (Series C)
  • • Get Spiffy: $10000000 (Series B)
  • • Field Effect Software: $35000000 (Series Unknown)
  • • Field Effect Software: $30000000 (Series A)
  • • SPHERE: $31000000 (Series B)
  • • Capital Rx: $110000000 (Series C)
  • • Capital Rx: $50000000 (Series B)
  • • Capital Rx: $12000000 (Series A)
  • • NS8: $120000000 (Series A)
  • • NS8: $26000000 (Seed)
  • • VirtualHealth: $14000000 (Series B)
  • • VirtualHealth: $7000000 (Series B)
  • • VirtualHealth: $7000000 (Series A)
  • • VirtualHealth: $3000000 (Seed)
  • • eSentire: $47000000 (Private Equity)
  • • eSentire: $20000000 (Series Unknown)
  • • eSentire: $13000000 (Series C)
  • • eSentire: $7000000 (Series B)
  • • Blue Medora: $10000000 (Series B)
  • • observIQ: $10000000 (Series B)
  • • Bricata: $8000000 (Series A)
  • • Lincor Solutions: $9500000 (Venture Round)
  • • Lincor Solutions: $10000000 (Series Unknown)
  • • Kemp: $16000000 (Series Unknown)
  • • KEMP Technologies: $16000000 (Venture Round)

Edison Partners

Princeton New Jersey, U.S.A.

Contact this investors  
Investing In

Software (Web Marketplace Saas..) • Other • IT (& TMT) • Education • Businesses Solutions • FinTech (& Financials services) • Retail (& E-Commerce) • IoT (& Wearables) • HealthTech (& Fitness) • Web Security (& Privacy) • Cloud Services (& Infrastructure) • Future Of Work • Human Resources • Logistics (& Distribution) • Investment Management • Woman Focused

Description

Most Interested In

Enterprise Software, Healthcare IT, and FinTech

main investor picture
    Strange Brew Ventures, LLC
    Investing in Software (Web Marketplace Saas..) &b...
     Shrewsbury New Jersey..., U.S.A.
    Investor Picture
    Previous Investments
    • • Sanctuary AI: (Seed)
    • • Lightmatter: $80000000 (Series B)
    • • FRNGE Inc.: $4000000 (Seed)
    • • Permanent Data Solutions Inc.: (Seed)

    Strange Brew Ventures, LLC

    Shrewsbury New Jersey - Atlanta Georgia - Houston Texas - Washington D.C - Usa - Trenton New Jersey - Seattle Washington - San Francisco - Richmond - Los Angeles, U.S.A.

    Contact this investors  
    Investing In

    Software (Web Marketplace Saas..) • Businesses Solutions • FinTech (& Financials services) • Retail (& E-Commerce) • A.I. (& Big Data) • Blockchain (& Cryptos) • Cloud Services (& Infrastructure) • GovTech • Robotics • Aerospace (& Defense) • Woman Focused

    Description

    Most Interested In

    Strange Brew makes direct investments or takes equity as payment for PR. We are a leading PR firm across AI, space/rockets, enterprise software, and more. Most interested in AI/ML seed stage companies, work-from-home technologies, space, automation, enterprise software.

    Not Interested In

    Yet-to-launch blockchain projects (unless heavily backed by VCs), health-tech, IoT.

    main investor picture
      Foundation Venture Capital Group
      Investing in Software (Web Marketplace Saas..) &b...
       ,
      • main investor picture
        Michael Wiley
        Vice President
      • main investor picture
        Aggie Worthington
        Vice President Finance
      • main investor picture
        Alexander Li
        Venture Associate
      • main investor picture
        Sara Soler
        Venture Associate
      • main investor picture
        James Golubieski
        Partner
      Investor Picture
      Previous Investments
      • • KayoThera: $750000 (Seed Round)
      • • Visikol Inc.: $500000 (Seed Round)
      • • NovoPedics: $500000 (Later stage VC)
      • • MentiNova: $500000 (Later stage VC)
      • • GeneAssess: $500000 (Later stage VC)
      • • Affineti Biologics: $500000 (Later stage VC)
      • • Snowdon: $500000 (Later stage VC)
      • • OculoMotor Technologies: $500000 (Seed Round)
      • • Actinobac Biomed: $100000 (Seed Round)

      Foundation Venture Capital Group

      ,

      Contact this investors  
      Investing In

      Software (Web Marketplace Saas..) • Businesses Solutions • Hardware (& Manufacturing) • Logistics (& Distribution) • Investment Management • Life Science

      Description

      Foundation Venture Capital Group is a venture capital firm based in Princeton, New Jersey. The firm primarily invests in the healthcare and health-related technology sectors.

      main investor picture
      Saturn Partners
      Investing in Software (Web Marketplace Saas..) &b...
       New York City , Nashv..., United States
      • main investor picture
        Jeffrey S. McCormick
      • main investor picture
        Edward Lafferty
        Partner and CFO
      • main investor picture
        Anne Bozik
        Senior Associate
      • main investor picture
        Jeffrey McCormick
        Managing Partner
      • main investor picture
        Bill Guttman
        Partner
      Investor Picture
      Previous Investments
      • • Knopp Biosciences: $78110000 (Later stage VC)
      • • Yieldstreet: (Seed)
      • • Yieldstreet: $4000000 (Seed)
      • • Trunomi: $3000000 (Seed)
      • • Trunomi: $3000000 (Seed)
      • • ClassWallet: $2000000 (Seed)
      • • ClassWallet: $2000000 (Seed)
      • • Overdog: $2000000 (Series Unknown)
      • • Overdog: $100000 (Seed)
      • • Overdog: $450000 (Seed)
      • • Overdog: $830000 (Seed)
      • • Nusirt: $6000000 (Series C)
      • • Nusirt: $4000000 (Series A)
      • • Nusirt: $2000000 (Seed)
      • • Nusirt: $600000 (Seed)
      • • Splitwise: $1000000 (Seed)
      • • CloudTags: $1000000 (Seed)
      • • U Grok It: $600000 (Angel)
      • • Learner-Centered Collaborative: $33000000 (Series A)
      • • Prompt.ly: $2000000 (Seed)
      • • Panopto: $2000000 (Debt Financing)
      • • Panopto: $4000000 (Series Unknown)
      • • Panopto: $2000000 (Series Unknown)
      • • August Home: $2000000 (Seed)
      • • 15Five: $1000000 (Seed)
      • • RedZone Robotics: $2000000 (Series Unknown)
      • • ClariFI: $4000000 (Series Unknown)

      Saturn Partners

      New York City - Nashville Tennessee - Pittsburgh Pennsylvania - Boston Massachusetts - Philadelphia Pennsylvania - Seattle Washington - Wayne New Jersey - St. Petersburgh, United States

      Contact this investors  
      Investing In

      Software (Web Marketplace Saas..) • IT (& TMT) • Media • Education • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Retail (& E-Commerce) • A.I. (& Big Data) • HealthTech (& Fitness) • Gaming (& eSports) • Analytics • Medical Devices (& Hospital Services) • Messaging • Life Science • Online Social • Pharmaceutical (& Medicine) • Diagnostics

      Description

      Saturn Partners is a venture capital firm based in Boston, Massachusetts. The firm was founded in 1994 and invests in the information technology, electronic commerce and financial technology, as well as select healthcare and advanced material applications.

      main investor picture
      Domain Associates
      Investing in Software (Web Marketplace Saas..) &b...
       New York , Princeton ..., United States
      • main investor picture
        Nicole Vitullo
        Partner
      • main investor picture
        Brian Dovey
        Partner
      • main investor picture
        Eckard Weber
        Partner
      • main investor picture
        Jesse Treu
        Partner
      • main investor picture
        Brian Halak
        Partner
      • main investor picture
        Adair Newhall
        Principal
      • main investor picture
        Kim P. Kamdar
        Partner
      • main investor picture
        Debra Liebert
        Investor
      • main investor picture
        Dennis Podlesak
        Investor
      • main investor picture
        James Blair
        Partner
      Investor Picture
      Previous Investments
      • • Iterum Therapeutics: $65000000 (Series B)
      • • Sebacia: $20000000 (Series D)
      • • Fractyl Laboratories: $44000000 (Later stage VC)
      • • Adynxx: $16000000 (Later stage VC)
      • • Antios Therapeutics: $75000000 (Series B)
      • • Antios Therapeutics: $96000000 (Series B)
      • • Antios Therapeutics: $25000000 (Series A)
      • • VentiRx Pharmaceuticals: $51000000 (Series B)
      • • VentiRx Pharmaceuticals: $51000000 (Series B)
      • • VentiRx Pharmaceuticals: $25000000 (Series A)
      • • VentiRx Pharmaceuticals: $27000000 (Series A)
      • • VentiRx Pharmaceuticals: $27000000 (Series A)
      • • Esperion: $33000000 (Series Unknown)
      • • Esperion: $23000000 (Series A)
      • • Marinus Pharmaceuticals: $21000000 (Series C)
      • • Marinus Pharmaceuticals: $20000000 (Series B)
      • • Marinus Pharmaceuticals: $29000000 (Series A)
      • • Celator Pharmaceuticals: $20000000 (Series D)
      • • Celator Pharmaceuticals: $23000000 (Series C)
      • • Celator Pharmaceuticals: $10000000 (Series C)
      • • Celator Pharmaceuticals: $20000000 (Series B)
      • • Achillion Pharmaceuticals: $50000000 (Post Ipo Equity)
      • • Achillion Pharmaceuticals: $50000000 (Post-IPO Equity)
      • • Xagenic: $12000000 (Series B)
      • • Xagenic: $26000000 (Series B)
      • • CoLucid Pharmaceuticals: $37000000 (Series C)
      • • CoLucid Pharmaceuticals: $8000000 (Series Unknown)
      • • CoLucid Pharmaceuticals: $25000000 (Series B)
      • • CoLucid Pharmaceuticals: $17000000 (Series A)
      • • Veracyte: $28000000 (Series C)
      • • Veracyte: $15000000 (Series Unknown)
      • • Veracyte: $28000000 (Series B)
      • • Afferent Pharmaceuticals: $5000000 (Series B)
      • • Afferent Pharmaceuticals: $23000000 (Series A)
      • • Regado Biosciences: $51000000 (Series E)
      • • Regado Biosciences: $40000000 (Series D)
      • • Regado Biosciences: $23000000 (Series C)
      • • Tandem Diabetes Care: $13000000 (Series B)
      • • NPS Pharmaceuticals: $5000000 (Seed)
      • • ReVision Optics: $32000000 (Series Unknown)
      • • ReVision Optics: $55000000 (Series E)
      • • ReVision Optics: $15000000 (Series E)
      • • ReVision Optics: $35000000 (Series D)
      • • ReVision Optics: $25000000 (Series D)
      • • Colorescience: $15000000 (Series B)
      • • Otonomy: $49000000 (Series D)
      • • Otonomy: $46000000 (Series C)
      • • Otonomy: $39000000 (Series B)
      • • Otonomy: $39000000 (Series B)
      • • VIVUS: (Seed)
      • • SonoThera: $61000000 (Series A)
      • • Immunitas Therapeutics: $58000000 (Series B)
      • • Dicerna Pharmaceuticals: $70000000 (Post Ipo Debt)
      • • Dicerna Pharmaceuticals: $60000000 (Series C)
      • • Bionano Genomics: $32000000 (Series D)
      • • Bionano Genomics: $10000000 (Series D)
      • • Bionano Genomics: $53000000 (Series C)
      • • Bionano Genomics: $10000000 (Series C)
      • • Bionano Genomics: $10000000 (Series B)
      • • Bionano Genomics: $23000000 (Series B)
      • • Kona Medical: $10000000 (Debt Financing)
      • • Kona Medical: $10000000 (Series C)
      • • Kona Medical: $30000000 (Series C)
      • • Carticept Medical: $10000000 (Series C)
      • • Carticept Medical: $20000000 (Series B)
      • • Carticept Medical: (Series A)
      • • Eddingpharm (Cayman): $24000000 (Series B)
      • • Corridor Pharmaceuticals: $13000000 (Series A)
      • • Alimera Sciences: $5000000 (Series C)
      • • Alimera Sciences: $30000000 (Series C)
      • • Alimera Sciences: $32000000 (Series B)
      • • Alimera Sciences: $27000000 (Series A)
      • • Oraya Therapeutics: $42000000 (Series C)
      • • Esprit Pharma: $25000000 (Series B)
      • • Esprit Pharma: $91000000 (Series B)
      • • Esprit Pharma: $100000000 (Series A)
      • • Vanda Pharmaceuticals: $19000000 (Series B)
      • • Milestone Pharmaceuticals: $80000000 (Series D)
      • • Milestone Pharmaceuticals: $55000000 (Series C)
      • • Milestone Pharmaceuticals: $17000000 (Series B)
      • • Epic Sciences: $24000000 (Series G)
      • • Epic Sciences: $52000000 (Series E)
      • • Epic Sciences: $40000000 (Series D)
      • • Epic Sciences: $30000000 (Series C)
      • • Epic Sciences: $13000000 (Series B)
      • • ROX Medical: $40000000 (Series E)
      • • ROX Medical: $6000000 (Series D)
      • • ROX Medical: $33000000 (Series C)
      • • ROX Medical: $10000000 (Series B)
      • • Sera Prognostics: $20000000 (Series B)
      • • Sera Prognostics: $5000000 (Series B)
      • • Sera Prognostics: $19000000 (Series A)
      • • Evofem Biosciences: $8000000 (Series C)
      • • Evofem Biosciences: $21000000 (Series C)
      • • Evofem Biosciences: $21000000 (Series C)
      • • Ariosa Diagnostics: $53000000 (Series C)
      • • BiPar Sciences: $20000000 (Series C)
      • • BiPar Sciences: $35000000 (Series B)
      • • Sonexa Therapeutics: $30000000 (Series A)
      • • Syndax Pharmaceuticals: $80000000 (Series C)
      • • Syndax Pharmaceuticals: $27000000 (Series B)
      • • Syndax Pharmaceuticals: $27000000 (Series B)
      • • Syndax Pharmaceuticals: $9000000 (Series A)
      • • Syndax Pharmaceuticals: $40000000 (Series A)
      • • RightCare Solutions: $5000000 (Series B)
      • • RightCare Solutions: $2000000 (Series A)
      • • Kalidex Pharmaceuticals: $7000000 (Series Unknown)
      • • Axial Biotherapeutics: $37000000 (Series C)
      • • Axial Biotherapeutics: $19000000 (Series A)
      • • Axial Biotherapeutics: $20000000 (Series A)
      • • Signifier Medical Technologies: $10000000 (Series C)
      • • ChromaCode: $28000000 (Series C)
      • • ChromaCode: $12000000 (Series B)
      • • Gene Sciences, Inc.: $8000000 (Series A)
      • • Applied Proteomics: $28000000 (Series C)
      • • Applied Proteomics: $23000000 (Series B)
      • • aTyr Pharma: $49000000 (Series D)
      • • aTyr Pharma: $23000000 (Series C)
      • • Ocunexus Therapeutics: $20000000 (Series B)
      • • Ocunexus Therapeutics: $19000000 (Series B)
      • • Ocunexus Therapeutics: $20000000 (Series A)
      • • Astute Medical: $40000000 (Series C)
      • • Astute Medical: $13000000 (Series B)
      • • Astute Medical: $27000000 (Series B)
      • • IntegenX: $40000000 (Series C)
      • • IntegenX: $16000000 (Series B)
      • • IntegenX: $18000000 (Series B)
      • • NeuroPace: $49000000 (Series Unknown)
      • • NeuroPace: $30000000 (Series Unknown)
      • • ProteinSimple: $33000000 (Series F)
      • • ProteinSimple: $10000000 (Series C)
      • • ProteinSimple: $27000000 (Series B)
      • • Zogenix: $15000000 (Series Unknown)
      • • Zogenix: $36000000 (Series B)
      • • Zogenix: $18000000 (Series B)
      • • Zogenix: $60000000 (Series A)
      • • GenVault: $13000000 (Series B)
      • • GenVault: $18000000 (Series Unknown)
      • • GenVault: $23000000 (Series A)
      • • GenVault: $13000000 (Series A)
      • • GenVault: $10000000 (Series A)
      • • Five Prime Therapeutics: $45000000 (Series Unknown)

      Domain Associates

      New York - Princeton New Jersey - San Diego, United States

      Contact this investors  
      Investing In

      Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • CleanTech • HealthTech (& Fitness) • Material Science • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Life Science • Oncology • Pharmaceutical (& Medicine)

      Description

      Domain Associates is a venture capital firm that was founded in 1985 and is based in Princeton, New Jersey. The firm invests in companies operating in therapeutics, medical devices, clinical diagnostics, healthcare and pharmaceutical sectors.

      main investor picture
        Thylacine Capital
        Investing in Businesses Solutions • FinTech ...
         Hoboken New Jersey , ..., U.S.A.
        • main investor picture
          Shay Grinfeld
          Managing Partner
        Investor Picture
        Previous Investments
        • • Coralogix: $140000000 (Series D)
        • • Coralogix: $55000000 (Series C)
        • • Quali: $54000000 (Series D)
        • • BigPanda: $23000000 (Series B)

        Thylacine Capital

        Hoboken New Jersey - New York, U.S.A.

        Contact this investors  
        Investing In

        Businesses Solutions • FinTech (& Financials services) • Consumer

        main investor picture
          Colchester Capital, LLC
          Investing in
           New Jersey, United States
          Investor Picture

          Colchester Capital, LLC

          New Jersey, United States

          Contact this investors  
          main investor picture
          New Jersey Economic Development Authority
          Investing in
           New Jersey - Trenton, United States
          Investor Picture

          New Jersey Economic Development Authority

          New Jersey - Trenton, United States

          Contact this investors  
          Description

          We are an economic development authority.

          main investor picture
          Cardinal Partners
          Investing in Software (Web Marketplace Saas..) &b...
           New Jersey - Princeton, United States
          • main investor picture
            John Clarke
            Managing Partner
          • main investor picture
            Thomas McKinley
            General Partner
          Investor Picture
          Previous Investments
          • • Privia Health: $400000000 (Other)
          • • Vividion Therapeutics: $50000000 (Early stage VC)
          • • Ivenix: $42000000 (Later stage VC)
          • • lifeIMAGE: $17641798 (Later stage VC)
          • • Cureatr: $13000000 (Later stage VC)
          • • Cardinal Analytx Solutions: $6100000 (Early stage VC)
          • • Cardinal Analytx:

          Cardinal Partners

          New Jersey - Princeton, United States

          Contact this investors  
          Investing In

          Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • CleanTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Life Science

          Description

          Cardinal Partners is a venture capital firm which invests in seed and early stage companies operating in the life sciences, biotechnology and healthcare sectors. The firm was established in 1996 and is based in Princeton, New Jersey.

          main investor picture
            Rosemark Capital
            Investing in Software (Web Marketplace Saas..) &b...
             New Jersey, United States
            • main investor picture
              Chris Kuenne
              Partner, Managing Director
            Investor Picture

            Rosemark Capital

            New Jersey, United States

            Contact this investors  
            Investing In

            Software (Web Marketplace Saas..) • Media • Businesses Solutions • FinTech (& Financials services) • HealthTech (& Fitness)

            main investor picture
              Friend Skoler & Co., Inc.
              Investing in HealthTech (& Fitness) • Logist...
               New Jersey, United States
              • main investor picture
                Steven Skoler
                Managing Director
              Investor Picture

              Friend Skoler & Co., Inc.

              New Jersey, United States

              Contact this investors  
              Investing In

              HealthTech (& Fitness) • Logistics (& Distribution) • Real Estate (& Construction)

              Join the community!
              Connect with investors & startup founders

              Most active VC firms in New Jersey?

              Top Angel Investors

              New Jersey's startup ecosystem benefits from the presence of active angel investors such as David S. Rose and Esther Dyson. These investors are known for their strategic investments in early-stage ventures, particularly in technology and healthcare sectors. Angel investor groups such as Jumpstart NJ Angel Network also play a crucial role in nurturing startups in the region.

              Leading Venture Capital Firms

              Prominent venture capital firms operating in New Jersey include Edison Partners and Tech Council Ventures. Edison Partners is renowned for its investments in fintech and healthcare IT, while Tech Council Ventures focuses on a broad range of sectors, including enterprise software and life sciences. These firms provide not only capital but also strategic guidance to their portfolio companies.

              Investment Size and Scope

              Investment sizes in New Jersey typically range from $100,000 to several million dollars, depending on the stage and sector of the startup. Angel investors often provide seed funding, while venture capital firms can lead Series A and beyond, offering substantial financial support to scale businesses.

              Number of Investments

              In recent years, the number of investments in New Jersey has been on the rise, with dozens of startups receiving funding annually. Both angel investors and venture capital firms are actively involved in numerous deals, contributing to the growth of the local startup ecosystem.

              Future Outlook of the Investment Market

              The investment market in New Jersey is expected to continue its upward trajectory, driven by the state's strong educational institutions and proximity to major financial hubs. Sectors such as biotechnology, fintech, and clean energy are anticipated to attract increased investor interest.

              Support and Mentorship

              Angel investors and venture capitalists in New Jersey provide more than just financial backing; they offer valuable mentorship and industry connections. This support is crucial for startups navigating the complexities of scaling their operations and entering new markets.

              Government and Institutional Support

              New Jersey's government and institutions such as the New Jersey Economic Development Authority (NJEDA) offer various programs and incentives to support startups. These initiatives aim to foster innovation and attract both domestic and international investments to the state.

              Conclusion

              New Jersey presents a fertile ground for startups, with a robust network of angel investors and venture capital firms. The state's supportive environment and strategic location make it an attractive destination for entrepreneurs seeking investment and growth opportunities.

              Comprehensive Guides to Raising Funds Online

              By clicking on "Create Account" you accept our terms of service

              Already have an account?
              Login
              Mike testimonial

              Michael Colin - Founder of The MVMT



              "We met the perfect Angel Investor within the Angels Partners Investors' Community. We received a $250,000 check after 2 months of discussions with investors on the platform."

              Taylor Testimonial

              Taylor Matter - Founder & CEO, Hurdle Apparel



              "Raising Capital for a consumer venture can be rather difficult and Angels Partners helped connect the dots and helped us meet 2 investors who invested $200,000 in our brand."

              founder clement

              Clément Perrot - Co-Founder & CEO of Prynt



              "Met really good investors who invested in Prynt, that I wouldn’t have met otherwise. Angels Partners helped us close our round quicker and with the right people."


              Create An Account
              Copyright © 2026 - All trademarks and copyrights belong to their respective owners.
              proof notifcation
              32 New StartupsStarted their fundraisingover the last 7 days